Clinical comparison of plasma substitutes, dextran and hydroxyethyl starch
Hayashi, K.; Higashi, H.
Masui. Japanese Journal of Anesthesiology 24(9): 853-859
1975
ISSN/ISBN: 0021-4892 PMID: 53296 Document Number: 94577
Document emailed within 1 workday
Related Documents
Jamnicki, M.; Zollinger, A.; Seifert, B.; Popovic, D.; Pasch, T.; Spahn, D.R. 1998: Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography Anesthesia and Analgesia 87(5): 989-993Ikeda, K.; Tanaka, S.; Mizutani, H.; Horii, D.; Arai, Y. 1971: Effect of hydroxyethyl starch on blood volume and extracellular fluid volume during hemorrhage--comparison with the effect of clinical dextran and re-infusion of autologous blood Masui. Japanese Journal of Anesthesiology 20(7): 639-647
Lorenz, W.; Doenicke, A.; Freund, M.; Schmal, A.; Dormann, P.; Praetorius, B.; Schürk-Bulich, M. 1975: Plasma histamine levels in man following infusion of hydroxyethyl starch: a contribution to the question of allergic or anaphylactoid reactions following administration of a new plasma substitute Der Anaesthesist 24(5): 228-230
Oda, A.; Aoki, A.; Ozaki, T.; Unno, K.; Nagai, N. 1972: Behavior of hydroxyethyl starch in the plasma and urine of man following intravenous infusion Masui. Japanese Journal of Anesthesiology 21(8): 747-753
Jesch, F.; Hübner, G.; Zumtobel, V.; Zimmermann, M.; Messmer, K. 1979: Hydroxyethyl starch (HAS 450/0.7) in human plasma and liver. Course of concentration and histological changes Infusionstherapie und Klinische Ernahrung 6(2): 112-117
Rabinerson, D.; Ben Rafael, Z.; Keslin, J.; Zolotarsky, V.; Dekel, A. 2001: 10% hydroxyethyl starch for plasma expansion in the treatment of severe ovarian hyperstimulation syndrome. A case report Journal of Reproductive Medicine 46(1): 68-70
Kitamura, Y.; Yamada, A.; Sha, N.; Hamai, R.; Nishimura, K. 1972: A clinical study of hydroxyethyl starch Osaka City Medical Journal 18(1): 21-36
Braga, V.M.; Kuz'mina, N.F.; Onoprienko, S.N.; Tsyganok, S.S. 1977: Plasma substitutes of the dextran series in therapy of some dermatoses Vestnik Dermatologii i Venerologii 4: 75-78
Ratajczak, J.; Szczepanik, A.B.; Meissner, A.J.; Ostas, A.; Wiszniewski, A.; Bilski, Rław. 2009: Small volume resuscitation for acute intraoperative haemorrhage: comparison of 7.5% saline and 6% hydroxyethyl starch Anestezjologia Intensywna Terapia 41(1): 6-10
Weidler, B.; von Bormann, B.; Sommermeyer, K.; Lohmann, E.; Peil, J.; Hempelmann, G. 1991: Pharmacokinetic parameters as criteria for clinical use of hydroxyethyl starch preparations Arzneimittel-Forschung 41(5): 494-498
Savić, J.; Pantelić, D.; Vujnov, S.; Zunić, O. 1977: Study on the efficacy of dextran, gelatin and human albumin solutions as plasma substitutes Vojnosanitetski Pregled 34(3): 197-203
Cherstvoĭ, E.D.; Nikoforov, I.E.; Vlasov, L.E.; Nerovnia, A.M. 1992: Tissue reactions in children treated with hemodynamic dextran and detoxication polyvinylpyrrolidone plasma substitutes Arkhiv Patologii 54(11): 21-27
Bunk, A.; Dapper, F.; Hata, H.; Neuhof, H.; Hehrlein, F.W. 1993: Experimental studies of the influence of priming solutions on the systemic activation of complement during cardiopulmonary bypass: comparison between the use of albumin, hydroxyethyl starch and HWA-138 Journal of Cardiovascular Surgery 34(2): 115-122
Kitamura, Y.; Yamada, A.; Sha, N.; Hamanaka, R.; Nishimura, K. 1972: Hespander (hydroxyethyl starch) Masui. Japanese Journal of Anesthesiology 21(11): 1121-1133
Meister, D.; Hermann, M.; Mathis, G.A. 1992: Kinetics of hydroxyethyl starch in horses Schweizer Archiv für Tierheilkunde 134(7): 329-339
Kościelak, J.; Gryszkiewicz, A.; Schier, J.; Góralski, S. 1977: Fate of C-14 labeled hydroxyethyl starch in mice Acta Haematologica Polonica 8(4): 303-307
Daszyński, J.; Gryszkiewicz, A.; Kościelak, J. 1976: Erythrocyte freezing in the presence of hydroxyethyl starch Acta Haematologica Polonica 7(2): 155-161
Köhler, H.; Kirch, W.; Vogt, J.; Höffler, D. 1977: Pharmacokinetics of hydroxyethyl starch in kidney failure Verhandlungen der Deutschen Gesellschaft für Innere Medizin 83: 1676-1678
Mishler, J.M. 1980: Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5 Infusionstherapie und Klinische Ernahrung 7(2): 96-102
Fiala, J. 1979: Use of hydroxyethyl starch in blood transfusion and hematology Vnitrni Lekarstvi 25(9): 897-902